Paul Tudor Jones Oric Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 29,205 shares of ORIC stock, worth $201,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,205Holding current value
$201,806% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
113Shares Held
59.3MCall Options Held
302KPut Options Held
7.7K-
Nextech Invest Ag5.29MShares$36.5 Million13.59% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$30.4 Million5.19% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$28.6 Million2.99% of portfolio
-
Viking Global Investors LP4MShares$27.6 Million0.21% of portfolio
-
Alkeon Capital Management LLC New York, NY3.7MShares$25.6 Million0.09% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $273M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...